Subsidiary Faces Drug License Suspension in Telangana; Potential Revenue Loss Cited
Medplus Health Services Ltd's subsidiary, Optival Health Solutions Private Limited, has received an order suspending a drug license for one of its stores located in Telangana. The action taken by the regulatory authority details the suspension and potential financial implications for the company as reported on June 19, 2026.The suspension relates to a store situated at Saleemnagar Malakpet, Telangana, issued by the Assistant Director, Drugs Control Administration, Secunderabad.
Key details regarding the licensing action are summarized below:
| Authority | Action Taken | Date of Receipt | Violation Alleged | Impact |
|---|---|---|---|---|
| Assistant Director, Drugs Control Administration, Secunderabad, Telangana. | Suspension of Drug License for one day of store. | 18.06.2026 | Contravention under Rule 65 of Drugs and Cosmetics Act, 1940 and Rules, 1945. | Potential Revenue Loss of Rs 0.47 lacs. |
The suspension concerns the drug license for one day of operation at the specified store location in Telangana. The impact on financial operations has been quantified as a potential revenue loss amounting to Rs 0.47 lacs.
MEDPLUS Stock Price Movement
Shares of Medplus Health Services Limited slipped by 0.69% in the trading session, closing today at ₹844.45. The stock moved within an intraday range spanning from a low of ₹840.75 to a high of ₹854.95, with 74,427 shares recorded for trade.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.